REFERENCES The economic burden of lung cancer and associated costs of treatment failure in the United States

REFERENCES
1. American Cancer Society. Statistics for 2006. Cancer Facts and Figures.
Available at: http://www.cancer.org/docroot/stt/stt_0.asp. Accessed
January 16, 2007.
2. Kutikova L. Bowman L, Chang S, et al. The economic burden of lung
cancer and associated costs of treatment failure in the United States.
Lung Cancer 2005;50:143–154.
3. Woodward RM, Brown ML, Stewart ST, et al. The value of medical interventions
for lung cancer in the elderly: results from SEER-CMHSF.
Cancer 2007;110:2511–2518.
4. Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the
cost of initial cancer treatment. J Natl Can Inst 2008;100:888–897.
5. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence
and second primary tumors in resected Stage I lung cancer. J Thorac
Cardiovasc Surg 1995;109:120–129.
6. Buell PE. The importance of tumor size in prognosis for resected bronchogenic
carcinoma. J Surg Oncol 1971;3:539–551.
7. Mountain CF. Revisions in the International System for Staging Lung
Cancer. Chest 1997;111:1710–1717.
8. Inoue K, Sato M, Fujimura S, et al. Prognostic assessment of 1310 patients
with non-small-cell lung cancer who underwent complete resection
from 1980 to 1993. J Thorac Cardiovasc Surg 1998;116:407–411.
9. SEER Relative Survival Rates by Stage at Diagnosis. SEER 9 Registries
for 1988–2003. Fast Stats: Lung and Bronchus Cancer. Available at:
http://seer.cancer.gov/faststats/sites.php?site=Lung%20and%20Bronc
hus%20Cancer&stat=Survival. Accessed August 14, 2009.
10. Henschke CI, Miettinen OS, Yankelevitz DF, et al. Radiographic
screening for cancer: New paradigm for its scientific basis. Clin Imaging
1994;18:16–20.
11. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer
Action Project: overall design and findings from baseline screening.
Lancet 1999;10;354:99–105.
12. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral Lung Cancer:
Screening and detection with low-dose spiral CT versus radiography.
Radiology 1996;201:798–802.
13. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile
spiral computed tomography scanner. Lancet 1998;351:1242–1245.
14. Henschke CI, Yankelevitz DF, Smith JP, et al. Screening for lung cancer:
the early lung cancer action approach. Lung Cancer 2002;35:143–148.
15. International Early Lung Cancer Action Program protocol. Available
online at: http://www.IELCAP.org. Accessed August 14, 2009.
16. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with
low-dose helical computed tomography: anti-lung cancer association
project. J Clin Oncol 2002;20:911–920.
17. International Early Lung Cancer Action Program Investigators;
Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients
with stage I lung cancer detected on CT screening. N Engl J Med
2006;355:1763–1771.
18. Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a
population-based 1996–1998 mass screening programme for lung cancer
using mobile low-dose spiral computed tomography. Lung Cancer
2007;58:329–341.
19. Berlin NI, Buncher CR, Fontana RS, et al. The National Cancer
Institute Cooperative Early Lung Cancer Detection Program. Results
of the initial screen (prevalence). Early lung cancer detection: introduction.
Am Rev Respir Dis 1984 Oct;130(4):545–549.
20. Flehinger BJ, Melamed MR, Zaman MB, et al. Early lung cancer
detection: results of the initial (prevalence) radiologic and cytologic
screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis
1984 Oct;130(4):555–560.
21. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung
cancer. Results of the Memorial Sloan-Kettering study in New York.
Chest 1984;86:44–53.
22. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection:
results of the initial (prevalence) radiologic and cytologic screening in
the Johns Hopkins study. Am Rev Respir Dis 1984;130:549–554.
23. Tockman MS. Survival and mortality from lung cancer in a screened
population. Chest 1986;89:S324–S326.
24. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer
detection: results of the initial (prevalence) radiologic and cytologic
screening in the Mayo Clinic study. Am Rev Respir Dis
1984;130:561–565.
25. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening:
the Mayo program. J Occup Med 1986;28:746–750.
26. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer.
A critique of the Mayo Lung Project. Cancer 1991;67:1155–1164.
27. Fontana RS. The Mayo Lung Project. International Conference on
Prevention and Early Diagnosis of Lung Cancer. Varese, Italy, Dec
9–10;1998:15–20.
28. Flehinger BJ, Kimmel M, Polyak T, et al. Screening for lung cancer.
The Mayo Lung Project revisited. Cancer 1993;73:1573–1580.
29. Miettinen OS. Screening for lung cancer. Radiol Clin North Am
2000;38:479–486.
30. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer.
Another look; a different view. Chest 1997;111:754–768.
31. Strauss GM. Screening for lung cancer: an evidence-based synthesis.
Surg Oncol Clin N Am 1999;8:747–774.
32. Prorok PC, Chamberlain J, Day NE, et al. UICC workshop on the evaluation
of screening programmes for cancer. Int J Cancer 1984;34:1–4.
33. Sobue T. A case-control study for evaluating lung cancer screening in
Japan. Cancer 2000;89:2392–2396.
34. Sagawa M, Tsubono Y, Saito Y, et al. A case-control study for evaluating
the efficacy of mass screening program for lung cancer in Miyagi
Prefecture, Japan. Cancer 2001 Aug 1;92:588–594.
35. Tsukada H, Kurita Y, Yokoyama A, et al. An evaluation of screening
for lung cancer in Niigata Prefecture, Japan: a population-based casecontrol
study. Br J Cancer 2001;85:1326–1331.
36. Nishii K, Ueoka H, Kiura K, et al. A case-control study of lung cancer
screening in Okayama Prefecture, Japan. Lung Cancer 2001;34:325–332.
37. Okamoto N, Suzuki T, Hasegawa H, et al. Evaluation of a clinicbased
screening program for lung cancer with a case-control design in
Kanagawa, Japan. Lung Cancer 1999;25:77–85.
38. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate,
Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control
Clin Trials 2000;21:S273–S309.
39. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from
colorectal cancer by screening for fecal occult blood. N Engl J Med
1993;328:1365–1371.
40. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occultblood
screening on the incidence of colorectal cancer. N Engl J Med
2000;343:1603–1607.
41. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action
project: initial findings on repeat screenings. Cancer 2001;92:153–159.
42. Henschke CI, Yankelevitz DF, Smith JP, et al. The use of spiral CT in
lung cancer screening. In: DeVita VT, Hellman S, Rosenberg SA, eds.
Progress in Oncology 2002. Sudbury, MA: Jones and Barlett, 2002.
43. New York Early Lung Cancer Action Project Investigators. CT screening
for lung cancer: diagnoses resulting from the New York Early Lung
Cancer Action Project. Radiology 2007;243:239–249.
44. International Early Lung Cancer Action Program Investigators. Survival
of patients with stage I lung cancer detected on CT screening. N Engl J
Med 2006;355:1763–1771.
45. Henschke CI, Smith JP, Miettinen OS. Response to letters to the editor.
N Engl J Med 2007;356:743–747.
46. Carter D, Vazquez M, Flieder DB, et al. Comparison of pathologic
findings of baseline and annual repeat cancers diagnosed on CT screening.
Lung Cancer 2007;56(2):193–199.
47. Henschke CI, Wisnivesky JP, Yankelevitz DF, et al. Small stage I cancers
of the lung: genuineness and curability. Lung Cancer 2003;39:327–330.
48. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell
lung cancer. Chest 2007;132:193–199.
49. Flehinger BJ, Kimmel M, Melamed MR. Survival from early lung cancer.
Implications for screening. Chest 1992;101:13–18.
50. Sobue T, Suzuki R, Matsuda M, et al. Survival for clinical stage I lung
cancer not surgically treated. Comparison between screen-detected and
symptom-detected cases. Cancer 1992;69:685–692.
51. Yankelevitz DF, Kostis WJ, Henschke CI, et al. Overdiagnosis in
chest radiographic screening for lung carcinoma: frequency. Cancer
2003;97:1271–1275.
52. Bill-Axelrod A, Holmberg L, Ruutu M, et al. Radical prostatectomy
versus watchful waiting in early prostate cancer. N Eng J Med
2005;352:1977–1984.
53. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for
lung cancer: Frequency and significance of part-solid and nonsolid
nodules. AJR Am J Roentgenol 2002;178:1053–1057.
54. Henschke CI, Shaham D, Yankelevitz DF, et al. CT screening for lung
cancer: significance of diagnoses in its baseline cycle. Clin Imaging
2006;30:11–15.
55. Henschke CI, Yip R, Yankelevitz DF, et al. Computed tomography
screening for lung cancer: competing causes of death. Clin Lung Cancer
2006;7:323–325.
56. Henschke CI, Yankelevitz DF, Naidich D, et al. CT screening for
lung cancer: suspiciousness of nodules at baseline according to size.
Radiology 2004;231:164–168.
57. Libby DM, Wu N, Lee IJ, et al. CT screening for lung cancer: the value
of short-term CT follow-up. Chest 2006;129:1039–1042.
58. Yankelevitz DF, Gupta R, Zhao B, et al. Repeat CT scanning for
evaluation of small pulmonary nodules: preliminary results. Radiology
1999;212:561–566.
59. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Determination of malignancy
in small pulmonary nodules based on volumetrically determined
growth rates: preliminary results. Radiology 2000;217:251–256.
60. Kostis WJ, Reeves AP, Yankelevitz DF, et al. Three-dimensional
segmentation and growth-rate estimation of small pulmonary
nodules in helical CT images. IEEE Tran Med Imaging 2003;22:
1259–1274.
61. Reeves A, Chan A, Yankelevitz D, et al. On measuring the change in size
of pulmonary nodules. IEEE Trans Med Imaging 2006;25:433–450.
62. Kostis WJ, Yankelevitz DF, Reeves AP, et al. Small pulmonary nodules:
reproducibility of three-dimensional volumetric measurement and estimation
of time to follow-up CT. Radiology 2004;231:446–452.
63. Henschke CI, Lee I, Wu N, et al. CT screening for lung cancer:
prevalence and incidence of mediastinal masses. Radiology 2006;239:
581–590.
64. Shemesh J, Henschke CI, Yip R, et al. Detection of coronary artery
calcification by age and gender on low-dose CT screening for lung.
Cancer Clin Imaging 2006;30:181–185.
65. Kostis WJ, Fluture S, Yankelevitz DF, et al. Method for analysis and
display of distribution of emphysema in CT scans. SPIE Medical
Imaging 2003;5032:199–206.
66. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality
in the Mayo Lung Project: impact of extended follow-up. J Natl
Cancer Inst 2000;92(16):1308–1316.
67. http://www.cancer.gov/nlst. Accessed December 27, 2009.
68. Henschke CI, Yankelevitz DF, Kostis WJ. CT screening for lung cancer.
Semin Ultrasound, CT, and MRI. 2003;24:23–32.
69. The American Cancer Society. Cancer of the lung. Cancer 1980;30:
199–207.
70. Smith RA, Mettlin CJ, Davis KJ, et al. American Cancer Society guidelines
for the early detection of cancer. Cancer 2000;50:34–49.
71. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer
Society guidelines for the early detection of cancer: update of early
detection guidelines for prostate, colorectal, and endometrial cancers:
Also: update 2001—testing for early lung cancer detection. Cancer
2001;51:38–75.
72. U.S. Preventive Services Task Force. Available at: http://www.ahrq.gov/
clinic/uspstfab.htm. Accessed December 7, 2007.
73. U.S. Preventive Services Task Force. Guide to Clinical Preventive
Services. Screening for Lung Cancer. Washington, D.C., 1989;45–47.
74. Humphrey LL, Johnson M, Teutsch S. Lung cancer screening with
sputum cytologic examination, chest radiography, and computed
tomography: an update of the U.S. Preventive Services Task Force. Ann
Intern Med 2004:140:738–753.
75. Benson K, Hartz AJ. A comparison of observational studies and randomized,
controlled trials. N Engl J Med 2000;342:1878–1886.
76. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational
studies, and the hierarchy of research designs. N Engl J Med
2000;342:1887–1892.
77. International Early Lung Cancer Action Program Investigators. CT
screening for lung cancer: individualizing the benefit of the screening.
Eur Resp J 2007;30: 843–847.
78. Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a
population-based 1996–1998 mass screening programme for lung cancer
using mobile low-dose spiral computed tomography scanner. Lung
Cancer 2007;58:329–341.
79. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using
low-dose spiral CT: results of baseline and 1-year follow-up studies.
Chest 2002;122:15–20.
80. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer:
five-year prospective experience. Radiology 2005;235:259–265.
81. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection
with spiral CT and positron emission tomography in heavy smokers:
2-year results. Lancet 2003;362:593–597.
82. Henschke CI, Austin JH, Bauer T, et al. Minority Report: CT screening
for lung cancer. J Thorac Imaging. 2005;20:324–325.
83. Medical professionalism in the new millennium: a physician charter.
Ann Intern Med 2002;136:243–246.